| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 33 | +60.61% | +1.90% | -0.16% | +2.06% | -0.77% | 0.89 |
| 14d | 33 | +60.61% | -3.62% | -0.77% | -2.85% | -4.63% | -1.14 |
| 30d | 33 | +75.76% | -7.10% | +0.51% | -7.61% | -9.62% | -2.38 |
| 60d | 33 | +78.79% | -5.10% | +2.89% | -7.99% | -12.78% | -2.97 |
| 90d | 33 | +66.67% | -4.46% | +3.66% | -6.84% | -12.90% | — |
| 180d | 33(7 pending) | +38.46% | -4.76% | +6.18% | -10.94% | +1.90% | — |
| 1y | 33(8 pending) | +84.00% | -12.73% | +5.52% | -18.25% | -33.19% | — |
| 2y | 33(10 pending) | +86.96% | -22.23% | +13.38% | -35.61% | -49.00% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,100 | $112.79 | $124.1K | 317,692 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,700 | $111.57 | $189.7K | 318,792 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 51,375 | $114.77 | $5.90M | 262,207 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,200 | $117.70 | $376.6K | 244,883 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 61,378 | $5.33 | $327.1K | 321,992 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 61,378 | — | — | 0 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 7,971 | $115.82 | $923.2K | 254,236 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 6,153 | $116.99 | $719.9K | 248,083 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,500 | $110.54 | $165.8K | 320,492 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 4,110 | $114.19 | $469.3K | 313,582 | Jun 30, 2026 | Jul 2, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 12,653 | $2.08 | $26.3K | 260,241 | Jun 2, 2026 | Jun 3, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,653 | — | — | 0 | Jun 2, 2026 | Jun 3, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 15,000 | $2.08 | $31.2K | 247,588 | May 18, 2026 | May 19, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 15,000 | — | — | 12,653 | May 18, 2026 | May 19, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 447 | $86.62 | $38.7K | 232,588 | Mar 4, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,519 | $85.04 | $214.2K | 234,472 | Mar 4, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,437 | $85.78 | $123.3K | 233,035 | Mar 4, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 492 | $84.00 | $41.3K | 236,991 | Mar 4, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,113 | $89.66 | $368.8K | 237,483 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 35,300 | — | — | 35,300 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,650 | — | — | 245,059 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,424 | $88.50 | $126.0K | 241,596 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,039 | $87.75 | $178.9K | 243,020 | Mar 2, 2026 | Mar 4, 2026 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 42,246 | — | — | 27,653 | Sep 17, 2025 | Sep 17, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 79,220 | $2.08 | $164.8K | 306,629 | Sep 17, 2025 | Sep 17, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 36,974 | — | — | 0 | Sep 17, 2025 | Sep 17, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 79,220 | $50.00 | $3.96M | 227,409 | Sep 17, 2025 | Sep 17, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 25,000 | $2.08 | $52.0K | 226,886 | Mar 31, 2025 | Apr 1, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 25,000 | — | — | 69,899 | Mar 31, 2025 | Apr 1, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 30,000 | — | — | 208,921 | Mar 3, 2025 | Mar 3, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 60,000 | Mar 3, 2025 | Mar 3, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 5,754 | $30.33 | $174.5K | 203,167 | Mar 3, 2025 | Mar 3, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,281 | $31.00 | $39.7K | 201,886 | Mar 3, 2025 | Mar 3, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | — | — | 94,899 | Jan 10, 2025 | Jan 13, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 178,921 | Jan 10, 2025 | Jan 13, 2025 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 25,000 | $2.08 | $52.0K | 168,554 | Jun 27, 2024 | Jun 28, 2024 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 25,000 | — | — | 104,899 | Jun 27, 2024 | Jun 28, 2024 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,301 | $42.39 | $55.2K | 142,606 | Mar 4, 2024 | Mar 4, 2024 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,378 | $41.41 | $98.5K | 143,907 | Mar 4, 2024 | Mar 4, 2024 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 255 | $43.26 | $11.0K | 142,351 | Mar 4, 2024 | Mar 4, 2024 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 187,500 | — | — | 187,500 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,250 | — | — | 146,285 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 115,035 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | — | — | 129,899 | Jun 2, 2023 | Jun 2, 2023 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,056 | $30.88 | $32.6K | 104,882 | Mar 2, 2023 | Mar 3, 2023 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 314 | $31.40 | $9.9K | 104,568 | Mar 2, 2023 | Mar 3, 2023 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 23,750 | — | — | 105,938 | Mar 1, 2023 | Mar 3, 2023 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 142,500 | — | — | 142,500 | Mar 1, 2023 | Mar 3, 2023 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 81,279 | Oct 21, 2022 | Oct 24, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | — | — | 139,899 | Oct 21, 2022 | Oct 24, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 71,279 | Oct 17, 2022 | Oct 17, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | — | — | 149,899 | Oct 17, 2022 | Oct 17, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 20,000 | — | — | 159,899 | May 3, 2022 | May 3, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 20,000 | $2.08 | $41.6K | 60,814 | May 3, 2022 | May 3, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,300 | — | — | 40,814 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 80,000 | — | — | 80,000 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | — | — | 179,899 | Jan 14, 2022 | Jan 14, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 27,514 | Jan 14, 2022 | Jan 14, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 15,000 | — | — | 36,974 | Jan 12, 2022 | Jan 14, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,151 | $52.13 | $372.8K | 18,936 | Jan 12, 2022 | Jan 14, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 6,427 | $51.21 | $329.1K | 26,087 | Jan 12, 2022 | Jan 14, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,422 | $53.27 | $75.7K | 17,514 | Jan 12, 2022 | Jan 14, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 15,000 | $2.08 | $31.2K | 32,514 | Jan 12, 2022 | Jan 14, 2022 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,987 | $54.32 | $107.9K | 17,814 | Dec 3, 2021 | Dec 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | — | — | 189,899 | Dec 3, 2021 | Dec 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 27,514 | Dec 3, 2021 | Dec 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 300 | $55.07 | $16.5K | 17,514 | Dec 3, 2021 | Dec 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,713 | $53.31 | $411.2K | 19,801 | Dec 3, 2021 | Dec 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 17,256 | Nov 23, 2021 | Nov 23, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | — | — | 199,899 | Nov 23, 2021 | Nov 23, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 17,256 | Sep 3, 2021 | Sep 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALEGRANT Stock grant | 10,000 | — | — | 209,899 | Sep 3, 2021 | Sep 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,500 | $60.50 | $90.7K | 7,256 | Sep 3, 2021 | Sep 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 8,500 | $60.05 | $510.4K | 8,756 | Sep 3, 2021 | Sep 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 5,506 | $46.66 | $256.9K | 11,494 | Jun 3, 2021 | Jun 4, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALEGRANT Stock grant | 10,000 | — | — | 219,899 | Jun 3, 2021 | Jun 4, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 4,494 | $47.13 | $211.8K | 7,256 | Jun 3, 2021 | Jun 4, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 17,256 | Jun 3, 2021 | Jun 4, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 7,000 | $2.08 | $14.6K | 7,000 | Apr 13, 2021 | Apr 13, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,000 | — | — | 229,899 | Apr 13, 2021 | Apr 13, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 8,195 | $60.17 | $493.1K | 0 | Mar 15, 2021 | Mar 15, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 8,195 | — | — | 234,061 | Mar 15, 2021 | Mar 15, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 8,195 | $2.08 | $17.0K | 8,195 | Mar 15, 2021 | Mar 15, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,805 | $60.07 | $108.4K | 0 | Mar 11, 2021 | Mar 15, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 1,805 | $2.08 | $3.8K | 1,805 | Mar 11, 2021 | Mar 15, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,805 | — | — | 242,256 | Mar 11, 2021 | Mar 15, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 7,699 | $50.46 | $388.5K | 2,301 | Mar 8, 2021 | Mar 8, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 2,300 | $51.28 | $117.9K | 1 | Mar 8, 2021 | Mar 8, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 10,000 | — | — | 244,061 | Mar 8, 2021 | Mar 8, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1 | $52.15 | $52 | 0 | Mar 8, 2021 | Mar 8, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 10,000 | $2.08 | $20.8K | 10,000 | Mar 8, 2021 | Mar 8, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,100 | $45.75 | $50.3K | 0 | Mar 3, 2021 | Mar 5, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 12,019 | $45.07 | $541.7K | 1,100 | Mar 3, 2021 | Mar 5, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 20,000 | — | — | 254,061 | Mar 3, 2021 | Mar 5, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 20,000 | $2.08 | $41.6K | 20,000 | Mar 3, 2021 | Mar 5, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | SALE Chief Financial Officer | 6,881 | $44.12 | $303.6K | 13,119 | Mar 3, 2021 | Mar 5, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,000 | — | — | 140,000 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| KYMR KYMERA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 32,904 | — | — | 32,904 | Aug 20, 2020 | Aug 21, 2020 ↗ | View → |